World Clinical Drug
|
2024, 45(3): 324-326
• Article •
Dulaglutide in the treatment of type 2 diabetes mellitus with uremia: a case report and literature review
Full
Haixia LIU, Shanshan ZHANG*
Affiliations
- Department of Endocrinology, Shengli Oilfield Central Hospital, Dongying 257034, Shandong Province, China
Published: 2024-03-10
doi: 10.13683/j.wph.2024.03.014
Outline
dulaglutide
/
type 2 diabetes mellitus
/
uremia
/
glucagon-like peptide-1
刘海霞, 张杉杉.
度拉糖肽治疗2型糖尿病伴尿毒症1例并文献复习.
世界临床药物,
2024
, 45
(3)
: 324
-326
.
DOI: 10.13683/j.wph.2024.03.014
Haixia LIU, Shanshan ZHANG.
Dulaglutide in the treatment of type 2 diabetes mellitus with uremia: a case report and literature review[J].
World Clinical Drug,
2024
, 45
(3)
: 324
-326
.
DOI: 10.13683/j.wph.2024.03.014
Year 2024 volume 45 Issue 3
14
2
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2024.03.014
- Receive Date:2023-11-28
- Online Date:2026-11-18
- Published:2024-03-10